Features | No. of patients | TGM2 | P | BNIP3 | P | ||
---|---|---|---|---|---|---|---|
High | Low | High | Low | ||||
Gender | |||||||
Female | 3(2.0%) | 0 | 3 | 0.283a | 1 | 2 | 0.194b |
Male | 145(98.0%) | 70 | 75 | 105 | 40 | ||
Age (years)c | |||||||
< 60 | 72(48.6%) | 35 | 37 | 0.755 | 52 | 20 | 0.875 |
≥60 | 76(51.4%) | 35 | 41 | 54 | 22 | ||
Histological grade | |||||||
Well | 70(47.3%) | 37 | 33 | 0.184 | 50 | 20 | 0.933 |
Moderately | 58(39.2%) | 22 | 36 | 41 | 17 | ||
Poorly | 20(13.5%) | 11 | 9 | 15 | 5 | ||
Smoking indexd | |||||||
< 600 | 67(45.3%) | 36 | 31 | 0.154 | 52 | 15 | 0.651 |
≥600 | 81(54.7%) | 34 | 47 | 54 | 27 | ||
Alcohol consumption | |||||||
No | 88(59.5%) | 40 | 48 | 0.587 | 56 | 32 | 0.009** |
Yes | 60(40.5%) | 30 | 30 | 50 | 10 | ||
Primary Site | |||||||
Glottic | 104(70.3%) | 50 | 54 | 0.433 | 74 | 30 | 0.791 |
Supraglottic | 39(26.3%) | 19 | 20 | 29 | 10 | ||
Subglottic | 5(3.4%) | 1 | 4 | 3 | 2 | ||
T Stage | |||||||
1-2 | 101(68.2%) | 47 | 54 | 0.785 | 71 | 30 | 0.600 |
3-4 | 47(31.8%) | 23 | 24 | 35 | 12 | ||
Cervical lymph node metastasis | |||||||
Positive | 19(12.8%) | 9 | 10 | 0.995 | 17 | 2 | 0.064 |
Negative | 129(87.2%) | 61 | 68 | 89 | 40 | ||
TNM Stage | |||||||
I-II | 96(64.9%) | 46 | 50 | 0.838 | 67 | 29 | 0.502 |
III-IV | 52(35.1%) | 24 | 28 | 39 | 13 | ||
Total radiation dose | |||||||
< 60 Gy | 61(41.2%) | 24 | 37 | 0.105 | 41 | 20 | 0.319 |
≥60 Gy | 87(58.8%) | 46 | 41 | 65 | 22 | ||
Margin | |||||||
Negative | 68(45.9%) | 38 | 30 | 0.054 | 50 | 18 | 0.635 |
Positive | 80(54.1%) | 32 | 48 | 56 | 24 | ||
BNIP3 | |||||||
High | 106(71.6%) | 57 | 49 | 0.012* | |||
Low | 42(28.4%) | 13 | 29 |